5-69374031-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_133338.3(RAD17):āc.211A>Gā(p.Lys71Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,611,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_133338.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAD17 | NM_133338.3 | c.211A>G | p.Lys71Glu | missense_variant | 5/19 | ENST00000354868.10 | NP_579916.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD17 | ENST00000354868.10 | c.211A>G | p.Lys71Glu | missense_variant | 5/19 | 1 | NM_133338.3 | ENSP00000346938 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152158Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249698Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135184
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1459134Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 726048
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152158Hom.: 0 Cov.: 30 AF XY: 0.0000404 AC XY: 3AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.244A>G (p.K82E) alteration is located in exon 2 (coding exon 2) of the RAD17 gene. This alteration results from a A to G substitution at nucleotide position 244, causing the lysine (K) at amino acid position 82 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at